The page is the record's research on the issuer — no analyst, no rating, no view. # Pharming Group N.V. (NASDAQ: PHAR) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Pharming Group N.V., listed on NASDAQ under ticker PHAR, with ISIN US71716E1055 and LEI 724500DCJ9MPG74JEH91. Its security type is recorded as non-operating entity type (other), and its segment is not on the record. Its sector is 2834 Pharmaceutical Preparations and its jurisdiction is the Netherlands. The issuer is listed and not halted. ## The disclosure read The record holds 25 filings in the window 2025-11-08 to 2026-11-08, on 23 filing days, all of type results. The median gap between filing days is 10.5 days. The latest filing is dated 2026-11-06, 2 days before the record date, and is of type results. The NASDAQ median cadence gap is 6.0 days with a median of 52 filings and a median latency of 5.0 days. The sector median cadence gap is 6.0 days with a median of 63.0 filings and a median latency of 4.0 days. ## Auditor The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04. ## Coverage The record holds eight research houses named on the issuer's investor-relations page: Oppenheimer & Co. Inc., Portzamparc / BNP Paribas, Canaccord Genuity, First Berlin Research, H.C. Wainwright, Jefferies, Van Lanschot Kempen and RBC Capital Markets. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001828316.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/PHAR (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.pharming.com/investors/analyst-coverage (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/PHAR (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/PHAR · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp